SCHEMBL4640639

SCHEMBL4640639

CCC(OC(=O)c1cc(Cl)c(Br)cc1C(=O)OC(CC)C(C)C)C(C)C

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 4/20 0.34
STING1 Q86WV6 1/20 0.33
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA12 O43570 1/20 0.32
CA9 Q16790 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
THRA P10827 1/20 0.31
THRB P10828 1/20 0.31
SOS1 Q07889 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640641 0.95 HSD17B10 (0.35) L3MBTL1HPGDSTING1ALDH1A1MEN1
SCHEMBL7194558 0.89 L3MBTL1 (0.40) L3MBTL1HPGDCA1CA2CA12
SCHEMBL4641173 0.86 ALDH1A1 (0.35) L3MBTL1HPGDCA1CA2CA12
SCHEMBL4641272 0.84 MEN1 (0.38) HPGDALDH1A1MEN1KMT2A
SCHEMBL4640087 0.84 L3MBTL1 (0.40) L3MBTL1HPGDSTING1CA1CA2
SCHEMBL4639929 0.84 UTS2R (0.34) L3MBTL1HPGDCA1CA2CA12
SCHEMBL4640681 0.84 HSD17B10 (0.40) L3MBTL1CA1CA2CA12CA9
SCHEMBL4640062 0.84 L3MBTL1 (0.37) L3MBTL1CA1CA2CA12CA9
SCHEMBL4641178 0.82 ALDH1A1 (0.40) HPGDALDH1A1MEN1KMT2ATHRA
SCHEMBL4639933 0.79 LMNA (0.34) HPGDCA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX L3MBTL1 4720/4885HPGD 9/4885STING1 4335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.